Triomics

Raised $22M in a Series B round, announced 27 May 2026.

Total raised
$22M

Latest round Series BCountry United StatesSector AI

Round

$22MSeries B, 27 May 2026

Battery-led Series B brings total funding above $36M to scale oncology AI after ARR grew roughly tenfold in a year.

Amount
$22M
Stage
Series B
Announced
27 May 2026
Lead
Battery Ventures
Other investors
Nexus Venture Partners, Lightspeed, Y Combinator, Oncology Ventures, Precision Health Informatics
Use of funds
Battery-led Series B brings total funding above $36M to scale oncology AI after ARR grew roughly tenfold in a year.
Checked
Amount and date matched across 2 press sources
Sources
Triomics raises $22M Series B for oncology AI goodwinlaw.com
Triomics raises $22M Series B for oncology AI pulse2.com
Newsletter Startup rounds, in your inbox.

Free. Unsubscribe anytime.

Company

Oncology-specific AI for chart abstraction and clinical trial workflows at cancer centers

Based in
New York, United States
Sector
AI
Website
triomics.com ↗

Links

Website
triomics.com ↗

Questions

How much has Triomics raised?

Triomics raised $22M in a Series B round, announced on 27 May 2026.

Who invested in Triomics?

Battery Ventures led. Investors include Battery Ventures, Nexus Venture Partners, Lightspeed, Y Combinator, Oncology Ventures and Precision Health Informatics.